Target intelligence / Profile preview

Small nucleolar RNA, SNORA40 (predicted) (SNORA40)

Target
SNORA40
Molecular classification
Other (non-coding RNA; small nucleolar RNA)
01

Overview

ENSG00000212455 (LOC124900534) appears to encode or represent a predicted small nucleolar RNA (SNORA40), which generally functions in RNA modification in the nucleus. However, there is no evidence that this gene is protein-coding, nor is there meaningful data to support a defined biological function, implication in disease, or suitability as a therapeutic target. Its annotation as "RNU6-622P" and "SNORA40 (predicted)" reflects current bioinformatics categorization without experimental validation or clinical implication[4]. ENSG00000212455 is not reported to encode a protein or a receptor, and is not described as a drug target in Open Targets or related drug/gene databases[1][4]. The "SNORA" prefix refers to small nucleolar RNAs, a class of non-coding RNAs generally involved in chemical modification of other RNAs, such as rRNA, but there are no specific function or disease data for this predicted gene[4]. There is no evidence of disease association, drug interactions, or biomarker potential, and it is not listed as a therapeutic target in the available literature or databases. ENSG00000212455 is a predicted, likely non-coding small nucleolar RNA gene with no evidence of validated biological function, disease relevance, or druggability. Information is limited and likely incomplete or purely bioinformatic in nature, suggesting this is not a relevant therapeutic target and indicating the entry is primarily computational with insufficient experimental evidence[4].

Other names
LOC124900534RNU6-622PSNORA40 (predicted)

Beyond the preview

Go deeper on Small nucleolar RNA, SNORA40 (predicted) (SNORA40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA, SNORA40 (predicted) (SNORA40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call